Rising Genetic Disorder Prevalence Drives Growth in the Genotyping Assay Market: The Driving Engine Behind Genotyping Assay Market Evolution in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Genotyping Assay Market Size Growth Forecast: What to Expect by 2025?
In recent times, the genotyping assay market has witnessed significant expansion. The market value is projected to rise from $33.98 billion in 2024 to $41.6 billion in 2025, indicating a compound annual growth rate (CAGR) of 22.4%. Factors contributing to this substantial growth during the historic period include the prevalent use of traditional glassware, cultural and lifestyle shifts, economic variables, the expansion of hospitality and foodservice industries, and trends in gift and decor.

How Will the Genotyping Assay Market Size Evolve and Grow by 2029?
In the coming years, an impressive growth surge is anticipated in the market size of the genotyping assay, which is projected to reach $95.5 billion in 2029, with a CAGR of 23.1%. The projected growth during the forecast period is attributed to factors such as personalization and customization, health and wellness trends, surge in e-commerce, intelligent and multifunctional glassware, and the trend of culinary and mixology. The forecast period will also witness significant trends like material advancements, unique shapes and designs, smart drinkware, beverage-specific glassware, and features fostering health and safety.

View the full report here:
https://www.thebusinessresearchcompany.com/report/genotyping-assay-global-market-report

What Drivers Are Propelling the Growth of Genotyping Assay Market Forward?
The growing occurrence of genetic diseases is anticipated to foster the expansion of the genotyping assay market. Genetic conditions are a collective term for medical issues stem from abnormalities or mutations in a person's DNA. Genotyping assays allow for a comparison of DNA between affected and healthy individuals, identifying any changes. This can determine specific genetic mutations or variations related to a certain genetic disease. For example, in mid-2023, Gene People, a charitable organization based in the UK that aids those with genetic diseases, revealed that one out of every 25 children in the UK suffers from a genetic disease. This impacts approximately 30,000 infants and young children in the UK, as well as over 2.4 million children and adults yearly. Consequently, the escalating occurrence of genetic diseases stimulates the genotyping assay market's growth. Genotyping Assay Market Driver: Surge in Personalized Medicine Requirement Boosts Genotyping Assay Market Growth

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13444&type=smp

Which Emerging Trends Are Transforming the Genotyping Assay Market in 2025?
Leading enterprises in the genotyping assay market are making strides in genomic research, particularly in the invention of CE-IVD marked assays to identify treatment-resistant HIV-1 variants. One such innovation is the Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit, a CE-IVD marked tool developed by Applied Biosystems. It employs Sanger sequencing-based assay to scrutinize positive HIV samples for genetic variants resistant to commonly used antiretroviral drugs. In January 2023, the US-based firm Thermo Fisher Scientific introduced this system, capable of identifying treatment-resistant HIV-1 strains. It possesses distinctive capabilities, including genome anomaly evaluation using HIV RNA, detection of drug resistance mutations via first-class Sanger sequencing technology, and its suitability for clinical application. The introduction of the Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit has contributed significantly by enhancing the detection accuracy of treatment-resistant HIV-1 strains, providing ready-to-use reagents and controls, compliance with regulatory standards, possessing high-performance features and harmonizing with existing sequencing platforms and workflows.

What Are the Key Segments in the Genotyping Assay Market?
The genotyping assay market covered in this report is segmented -

1) By Product And Service: Reagents And Kits, Genotyping Services, Instruments, Bioinformatics
2) By Technology: Microarrays, Polymerase Chain Reaction, Sequencing, Capillary Electrophoresis, Matrix-assisted Laser Desorption Or Ionization-Time Of Flight Mass Spectrometry, Other Technologies
3) By End-User: Pharmacogenomics, Personalized Medicine And Diagnostics, Animal Genetics, Agricultural Biotechnology, Research And Diagnostic Laboratories, Academic Institutes

Subsegments:
1) By Reagents And Kits: DNA Extraction Kits, PCR Reagents, SNP Genotyping Kits, Genotyping Services, Genotyping by PCR, Whole Genome Sequencing Services, SNP Genotyping Services
2) By Instruments: PCR Machines, Sequencing Instruments, Microarrays
3) By Bioinformatics: Data Analysis Software, Genotyping Data Management Tools

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13444&type=smp

Who Are the Key Players Shaping the Genotyping Assay Market's Competitive Landscape?
Major companies operating in the genotyping assay market report are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Danaher Corporation, Eurofins Scientific SE, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen NV, BGI Genomics, LGC Biosearch Technologies, GenScript Biotech, Inotiv Inc., Promega Corporation, Luminex Corporation, Integrated DNA Technologies Inc., Integrated DNA Technologies Ltd., Sequenom Inc., 23andMe Inc., Novogene Corporation, Oxford Nanopore Technologies PLC, GenMark Diagnostics Inc., Macrogen Inc., Pacific Biosciences of California Inc., Standard BioTools Inc., Genewiz Inc., New England Biolabs, TrimGen Corporation, Xcelris Genomics

What Geographic Markets Are Powering Growth in the Genotyping Assay Market?
North America was the largest region in the genotyping assay market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genotyping assay market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13444

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.